Masimo Corporation (MASI) Analysts See $0.61 EPS

February 21, 2018 - By Peter Erickson

 Masimo Corporation (MASI) Analysts See $0.61 EPS
Investors sentiment increased to 1.18 in 2017 Q3. Its up 0.07, from 1.11 in 2017Q2. It improved, as 33 investors sold Masimo Corporation shares while 92 reduced holdings. 35 funds opened positions while 112 raised stakes. 42.22 million shares or 0.82% less from 42.57 million shares in 2017Q2 were reported.
Amalgamated National Bank & Trust, a New York-based fund reported 6,202 shares. Mufg Americas accumulated 90 shares. Art Advsrs Limited Liability Company owns 11,018 shares. Clinton Gp stated it has 0.71% in Masimo Corporation (NASDAQ:MASI). Ftb reported 414 shares stake. Meritage Port accumulated 54,074 shares. Moreover, Eaton Vance Management has 0.01% invested in Masimo Corporation (NASDAQ:MASI) for 32,400 shares. Hillsdale Inv Management reported 15,870 shares stake. Oakbrook Ltd Co holds 0.02% or 3,250 shares. M&T Retail Bank Corporation accumulated 7,987 shares. Usa Fincl Portformulas invested in 16,628 shares. Hbk Invests Ltd Partnership stated it has 78,446 shares or 0.05% of all its holdings. Oppenheimer Asset Mgmt reported 7 shares stake. Envestnet Asset stated it has 8,889 shares or 0% of all its holdings. Thompson Siegel & Walmsley Lc holds 450 shares or 0% of its portfolio.

Since January 4, 2018, it had 0 insider buys, and 4 insider sales for $2.18 million activity. On Thursday, January 25 FITCH SANFORD sold $180,000 worth of Masimo Corporation (NASDAQ:MASI) or 2,000 shares.

Analysts expect Masimo Corporation (NASDAQ:MASI) to report $0.61 EPS on February, 27 after the close.They anticipate $0.10 EPS change or 19.61 % from last quarter’s $0.51 EPS. MASI’s profit would be $31.52M giving it 35.00 P/E if the $0.61 EPS is correct. After having $0.70 EPS previously, Masimo Corporation’s analysts see -12.86 % EPS growth. The stock decreased 0.22% or $0.19 during the last trading session, reaching $85.39. About 318,105 shares traded. Masimo Corporation (NASDAQ:MASI) has risen 77.37% since February 22, 2017 and is uptrending. It has outperformed by 60.67% the S&P500.

Masimo Corporation (NASDAQ:MASI) Ratings Coverage

Among 8 analysts covering Masimo (NASDAQ:MASI), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Masimo had 14 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by Piper Jaffray on Wednesday, August 2 with “Hold”. The stock of Masimo Corporation (NASDAQ:MASI) has “Hold” rating given on Thursday, September 21 by Piper Jaffray. The stock of Masimo Corporation (NASDAQ:MASI) has “Buy” rating given on Thursday, August 3 by Stifel Nicolaus. The firm has “Hold” rating given on Tuesday, October 31 by Piper Jaffray. Roth Capital maintained the shares of MASI in report on Wednesday, July 19 with “Buy” rating. The stock has “Buy” rating by TH Capital on Wednesday, August 5. Roth Capital maintained the shares of MASI in report on Thursday, August 3 with “Buy” rating. On Monday, August 14 the stock rating was upgraded by BTIG Research to “Buy”. PiperJaffray downgraded Masimo Corporation (NASDAQ:MASI) on Thursday, March 16 to “Neutral” rating. The company was downgraded on Wednesday, January 6 by Raymond James.

Masimo Corporation, a medical technology company, develops, makes, and markets noninvasive monitoring technologies worldwide. The company has market cap of $4.41 billion. The firm offers Masimo Signal Extraction Technology pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It has a 13.69 P/E ratio. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin saturation; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.

More news for Masimo Corporation (NASDAQ:MASI) were recently published by:, which released: “Masimo Corp. (MASI) Announces FDA Clearance of Next Generation SedLine Brain …” on January 29, 2018.‘s article titled: “Form SC 13G/A MASIMO CORP Filed by: JANUS CAPITAL MANAGEMENT LLC” and published on February 06, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.